Clinical study offer

🩸 Paid Deep Vein Thrombosis Clinical Trials

Browse recruiting deep vein thrombosis clinical trials across the United States. Find eligibility information, locations and research opportunities near you.

Loading...
Active Studies
Deep Vein Thrombosis
Condition

Active Clinical Trials for Deep Vein Thrombosis

Showing live studies from ClinicalTrials.gov. Data refreshes daily.

Loading studies...

Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.

About Deep Vein Thrombosis

Deep Vein Thrombosis (DVT) is a blood clot that forms in a deep vein, usually in the legs, that can be life-threatening if it travels to the lungs. Clinical trials investigate novel anticoagulants, compression therapies, and thrombus removal techniques.

Common Symptoms

Leg swelling, pain or tenderness, warmth over the affected area, red or discolored skin, visible surface veins, leg cramping (often in calf)

Risk Factors

Prolonged immobility, surgery or trauma, cancer, pregnancy, obesity, smoking, oral contraceptives, age (over 60), inherited clotting disorders, family history

Treatment Overview

Treatment includes anticoagulant medications (warfarin, heparin, DOACs), compression stockings, and in severe cases, thrombectomy or thrombolysis. Clinical trials explore factor XI inhibitors with lower bleeding risk, novel reversal agents, and catheter-directed thrombolysis techniques.

Why Participate?

DVT clinical trials help develop safer anticoagulants with lower bleeding risk and improved strategies for preventing post-thrombotic syndrome.

Related Conditions

States with Deep Vein Thrombosis Clinical Trials

Cities with Deep Vein Thrombosis Clinical Trials

Frequently Asked Questions About Deep Vein Thrombosis Clinical Trials

DVT clinical trials test new blood thinners, clot removal techniques, and compression therapies to treat deep vein clots and prevent complications. Studies aim to reduce bleeding risk while maintaining effectiveness.
Eligibility depends on clot location and extent, prior DVT history, bleeding risk factors, and underlying causes including genetic clotting disorders.
Compensation varies. Participants typically receive $50-$200 per visit with ultrasound monitoring and study medications provided at no cost.
Yes, participants receive close monitoring including regular blood tests and imaging. All trials have safety protocols to manage any bleeding complications.